If the U.K. leaves the EU with no deal, it could be “catastrophic” for medicine supplies — and necessitate emergency powers, the pharmaceuticals industry says.
As pharmaceutical companies have faced more heat for their pricing practices, they’ve found someone else to blame: “middlemen” who extract discounts from drugmakers.
The term “forensic science” conjures up images of police dramas and crime investigations. But it turns out to have a strong connection to global supply chains, too.
The sky isn’t falling. That’s the message coming from Corporate America after President Trump reached a deal to revise the North American Free Trade Agreement.
There’s a lot to digest in the new trade agreement that the United States, Mexico and Canada finalized in deadline-beating fashion on Sunday, starting with a name change.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.